Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-31

FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings (PAI Pharma), confirming approval of a generic fluoxetine product under a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)